| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | insulin-like growth factor receptor binding | 2.66e-04 | 18 | 27 | 2 | GO:0005159 | |
| Domain | TSP_1 | 3.72e-03 | 63 | 27 | 2 | PF00090 | |
| Domain | TSP1 | 3.96e-03 | 65 | 27 | 2 | SM00209 | |
| Domain | TSP1_rpt | 3.96e-03 | 65 | 27 | 2 | IPR000884 | |
| Domain | TSP1 | 3.96e-03 | 65 | 27 | 2 | PS50092 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 16822937 | ||
| Pubmed | Development of vascular renin expression in the kidney critically depends on the cyclic AMP pathway. | 6.71e-07 | 2 | 29 | 2 | 19261741 | |
| Pubmed | 1.44e-04 | 1440 | 29 | 7 | 30833792 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 4.97e-04 | 807 | 29 | 5 | 30575818 | |
| Pubmed | 5.93e-04 | 43 | 29 | 2 | 33472061 | ||
| Pubmed | 8.02e-04 | 50 | 29 | 2 | 37974198 | ||
| Cytoband | 10q26.13 | 2.67e-04 | 38 | 29 | 2 | 10q26.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q14 | 3.36e-03 | 136 | 29 | 2 | chr5q14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q26 | 7.58e-03 | 207 | 29 | 2 | chr10q26 | |
| Coexpression | GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP | 2.43e-05 | 166 | 27 | 4 | M344 | |
| Coexpression | GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP | 4.65e-05 | 196 | 27 | 4 | M3668 | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 1.01e-06 | 21 | 28 | 3 | OBA_2045083 | |
| Disease | lysophosphatidylcholine measurement | 2.79e-05 | 62 | 28 | 3 | EFO_0010224 | |
| Disease | level of Phosphatidylcholine (16:0_22:4) in blood serum | 3.11e-05 | 9 | 28 | 2 | OBA_2045078 | |
| Disease | level of Sterol ester (27:1/20:5) in blood serum | 4.75e-05 | 11 | 28 | 2 | OBA_2045197 | |
| Disease | level of Phosphatidylinositol (18:0_20:3) in blood serum | 5.70e-05 | 12 | 28 | 2 | OBA_2045157 | |
| Disease | level of Phosphatidylcholine (O-16:0_20:4) in blood serum | 6.73e-05 | 13 | 28 | 2 | OBA_2045116 | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 7.85e-05 | 14 | 28 | 2 | OBA_2045100 | |
| Disease | level of Phosphatidylethanolamine (18:2_0:0) in blood serum | 7.85e-05 | 14 | 28 | 2 | OBA_2045143 | |
| Disease | lysophosphatidylcholine 22:5 measurement | 7.85e-05 | 14 | 28 | 2 | EFO_0021462 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement | 7.85e-05 | 14 | 28 | 2 | EFO_0022085 | |
| Disease | sleep duration, triglyceride measurement | 1.31e-04 | 104 | 28 | 3 | EFO_0004530, EFO_0005271 | |
| Disease | level of Phosphatidylcholine (20:4_0:0) in blood serum | 1.32e-04 | 18 | 28 | 2 | OBA_2045110 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 1.32e-04 | 18 | 28 | 2 | OBA_2045065 | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 1.80e-04 | 21 | 28 | 2 | OBA_2045104 | |
| Disease | level of Phosphatidylcholine (16:0_20:4) in blood serum | 1.80e-04 | 21 | 28 | 2 | OBA_2045076 | |
| Disease | gamma-linolenic acid measurement | 2.37e-04 | 24 | 28 | 2 | EFO_0007762 | |
| Disease | alpha-linolenic acid measurement | 2.57e-04 | 25 | 28 | 2 | EFO_0007759 | |
| Disease | lysophosphatidylethanolamine 18:2 measurement | 2.78e-04 | 26 | 28 | 2 | EFO_0010369 | |
| Disease | level of Phosphatidylcholine (17:0_20:4) in blood serum | 2.78e-04 | 26 | 28 | 2 | OBA_2045087 | |
| Disease | docosapentaenoic acid measurement | 3.00e-04 | 27 | 28 | 2 | EFO_0006809 | |
| Disease | phosphatidylcholine 38:4 measurement | 3.23e-04 | 28 | 28 | 2 | EFO_0010386 | |
| Disease | level of Phosphatidylethanolamine (18:0_18:2) in blood serum | 3.23e-04 | 28 | 28 | 2 | OBA_2045139 | |
| Disease | lysophosphatidylethanolamine 20:4 measurement | 3.47e-04 | 29 | 28 | 2 | EFO_0010370 | |
| Disease | level of Sterol ester (27:1/20:4) in blood serum | 3.97e-04 | 31 | 28 | 2 | OBA_2045198 | |
| Disease | level of Phosphatidylcholine (18:0_20:4) in blood serum | 3.97e-04 | 31 | 28 | 2 | OBA_2045094 | |
| Disease | lysophosphatidylcholine 20:3 measurement | 6.62e-04 | 40 | 28 | 2 | EFO_0010362 | |
| Disease | lysophosphatidylethanolamine measurement | 6.96e-04 | 41 | 28 | 2 | EFO_0010225 | |
| Disease | fatty acid measurement | 7.27e-04 | 436 | 28 | 4 | EFO_0005110 | |
| Disease | insomnia measurement | 7.71e-04 | 443 | 28 | 4 | EFO_0007876 | |
| Disease | cholesteryl ester 20:4 measurement | 8.01e-04 | 44 | 28 | 2 | EFO_0010348 | |
| Disease | cholesteryl ester 20:5 measurement | 8.01e-04 | 44 | 28 | 2 | EFO_0010349 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SRTKRWATCVRTACC | 611 | P84996 | |
| SCSDEKVRFWRCRVT | 991 | Q9Y485 | |
| TYKCTRDQWTVYCRV | 1046 | Q8TE56 | |
| LRAIAWKCTKDTTTY | 171 | A8K010 | |
| ATSWSRRLKVFLCCT | 191 | Q9Y4D2 | |
| CSRVYWSTTDARKRC | 2051 | Q03164 | |
| WSTTDARKRCVYTCK | 2056 | Q03164 | |
| WVCCIPYSTRKRAKE | 196 | A0A1B0GUA9 | |
| EKVRFERQKAWCCST | 746 | Q5FWF5 | |
| VTRYKTVTQLEWRCC | 96 | Q9BXX0 | |
| CVSRSKRDISSYKWK | 516 | Q86UP6 | |
| SSWTTCDPCQKKRYR | 71 | P07358 | |
| CRRKWKTIVQDYICS | 221 | O14827 | |
| WVPSSKCSRLYTACV | 111 | P00797 | |
| QTRWTCYKCSSSNKV | 1301 | Q8N3P4 | |
| KCPRCWKYTAESSDT | 986 | Q9NSE4 | |
| TRKCFVCKMYTARWV | 351 | Q92966 | |
| ASRRCWTCSRAQLKK | 51 | Q8IY50 | |
| KASSTRTWKEVCFAC | 1246 | P53675 | |
| LCLTKAAYCRCWRSK | 91 | Q8N5K1 | |
| ALKGWSCCKRRTTDF | 36 | Q9UHD1 | |
| REYWQVCTLLKCKTT | 396 | O95498 | |
| ESWKCDICKKSFTRR | 461 | Q5SVQ8 | |
| KWTCFICGKSVRERT | 546 | Q5SVQ8 | |
| SYEKGSTQRCCRKWI | 161 | Q70EL3 | |
| KRWQCPTCEKSYTSK | 251 | Q8N895 | |
| TFWKKDRSCRSLDVC | 386 | Q9BXG8 | |
| WRTHTKENIYECSKC | 376 | Q2M3X9 | |
| SVCTYENWAKAKRCV | 156 | Q9UGI0 | |
| CKLKRTSPTAYCDCW | 1221 | O95071 | |
| TITTLYCCRRRKQWK | 511 | O15146 |